Correction: Wang et al. Antibacterial Efficacy of Feline-Derived Lactic Acid Bacteria against Enteropathogenic Escherichia coli: A Comprehensive In Vitro Analysis. Fermentation 2024, 10, 514

Some paragraphs were missing from the original publication [1].

We have now made corrections throughout the manuscript to the Results (Section 3.8.4) and Discussion (Section 4).

In Section 3.8.4, we have added “Among the isolates tested, Ligilactobacillus agilis ZY25 and Ligilactobacillus salivarius ZY35 showed the highest antibacterial activity, with inhibition zones exceeding 22 mm. These strains demonstrated superior resilience in acidic conditions and tolerance to gastrointestinal fluids, making them promising candidates for probiotic applications”.

In Section 4, we added “Many studies focus on the use of probiotics like Lactobacillus spp., but our research emphasizes the efficacy of Ligilactobacillus agilis ZY25 and Ligilactobacillus salivarius ZY35. Ligilactobacillus salivarius has been shown to improve growth performance and antioxidative capacity in broiler chickens by modulating the microbiota–gut–brain axis, making it an effective probiotic for poultry. The strain also enhanced digestive enzyme secretion and positively impacted body weight and hormonal balance [44]. Similarly, Ligilactobacillus salivarius MP100, used in swine production, improved growth performance and fecal microbiota profiles without affecting meat quality, offering an alternative to metaphylactic antimicrobials and reducing antibiotic use [45]. Both strains exhibit substantial antibacterial activity against Escherichia coli, especially enteropathogenic strains, and their robust performance under simulated gastrointestinal conditions highlights their potential as host-specific probiotics, crucial for improving colonization and efficacy in feline gastrointestinal health”.

44.

Yang, J.; Wang, J.; Liu, Z.; Chen, J.; Jiang, J.; Zhao, M.; Gong, D. Ligilactobacillus salivarius improve body growth and anti-oxidation capacity of broiler chickens via regulation of the microbiota-gut-brain axis. BMC Microbiol. 2023, 23, 395. https://doi.org/10.1186/s12866-023-03135-x.

45.

Alba, C.; Castejón, D.; Remiro, V.; Rodríguez, J.M.; Sobrino, O.J.; de María, J.; Fumanal, P.; Fumanal, A.; Cambero, M.I. Ligilactobacillus salivarius MP100 as an alternative to metaphylactic antimicrobials in swine: The impact on production parameters and meat composition. Animals 2023, 13, 1653. https://doi.org/10.3390/ani13101653.

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.